Lenvatinib-induced thyroid abnormalities in unresectable hepatocellular carcinoma.
Koizumi Y, Hirooka M, Hiraoka A, Ochi H, Tanaka T, Yukimoto A, Imai Y, Watanabe T, Yoshida O, Miyake T, Matsuura B, Michitaka K, Joko K, Abe M, Hiasa Y.
Endocr J. 2019 Sep 28;66(9):787-792. doi: 10.1507/endocrj.EJ19-0140. Epub 2019 May 30.
PMID:31142692
Clinical pathological impacts of microRNAs in papillary thyroid carcinoma: A crucial review.